Cannabinoids Ameliorate Pain and Reduce Disease Pathology in Cerulein-Induced Acute Pancreatitis

Gastroenterology

Volumn 132, Issue 5, 2007, Pages 1968-1978

  Michalski, Christoph W ^a   Laukert, Tamara ^a   Sauliunaite, Danguole ^a   Pacher, Pál ^b   Bergmann, Frank ^a   Agarwal, Nitin ^a   Su, Yun ^a   Giese, Thomas ^a   Giese, Nathalia A ^a   Bátkai, Sándor ^b   Friess, Helmut ^a   Kuner, Rohini ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CANNABINOID; CERULETIDE; CHEMOKINE; CYTOKINE; DEXANABINOL; MYELOPEROXIDASE; TRIACYLGLYCEROL LIPASE;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIORAL SCIENCE; BIOPSY; CATALEPSY; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGHT DARK CYCLE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROLOGY; UPREGULATION;

EID: 34247868060     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.02.035     Document Type: Article

References (23)

1. Mayerle J., Hlouschek V., and Lerch M.M. Current management of acute pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 473-483
2. Toouli J., Brooke-Smith M., Bassi C., Carr-Locke D., Telford J., Freeny P., Imrie C., and Tandon R. Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol 17 Suppl (2002) S15-S39
3. Vera-Portocarrero L.P., Yie J.X., Kowal J., Ossipov M.H., King T., and Porreca F. Descending facilitation from the rostral ventromedial medulla maintains visceral pain in rats with experimental pancreatitis. Gastroenterology 130 (2006) 2155-2164
4. Kawabata A., Matsunami M., Tsutsumi M., Ishiki T., Fukushima O., Sekiguchi F., Kawao N., Minami T., Kanke T., and Saito N. Suppression of pancreatitis-related allodynia/hyperalgesia by proteinase-activated receptor-2 in mice. Br J Pharmacol 148 (2006) 54-60
5. Winston J.H., Toma H., Shenoy M., He Z.J., Zou L., Xiao S.Y., Micci M.A., and Pasricha P.J. Acute pancreatitis results in referred mechanical hypersensitivity and neuropeptide up-regulation that can be suppressed by the protein kinase inhibitor k252a. J Pain 4 (2003) 329-337
6. Nathan J.D., Peng R.Y., Wang Y., McVey D.C., Vigna S.R., and Liddle R.A. Primary sensory neurons: a common final pathway for inflammation in experimental pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol 283 (2002) G938-G946
7. Massa F., Storr M., and Lutz B. The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract. J Mol Med 83 (2005) 944-954
8. Ibrahim M.M., Porreca F., Lai J., Albrecht P.J., Rice F.L., Khodorova A., Davar G., Makriyannis A., Vanderah T.W., Mata H.P., and Malan Jr. T.P. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci U S A 102 (2005) 3093-3098
9. Pacher P., Batkai S., and Kunos G. The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacol Rev 58 (2006) 389-462
10. Wang L., Liu J., Harvey-White J., Zimmer A., and Kunos G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci U S A 100 (2003) 1393-1398
11. Massa F., Marsicano G., Hermann H., Cannich A., Monory K., Cravatt B.F., Ferri G.L., Sibaev A., Storr M., and Lutz B. The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest 113 (2004) 1202-1209
12. Tappe A., and Kuner R. Regulation of motor performance and striatal function by synaptic scaffolding proteins of the Homer1 family. Proc Natl Acad Sci U S A 103 (2006) 774-779
13. Pertwee R.G. The ring test: a quantitative method for assessing the "cataleptic" effect of cannabis in mice. Br J Pharmacol 46 (1972) 753-763
14. Erkan M., Kleeff J., Esposito I., Giese T., Ketterer K., Buchler M.W., Giese N.A., and Friess H. Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene 24 (2005) 4421-4432
15. Frossard J.L., Kwak B., Chanson M., Morel P., Hadengue A., and Mach F. Cd40 ligand-deficient mice are protected against cerulein-induced acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 121 (2001) 184-194
16. Lupia E., Goffi A., De Giuli P., Azzolino O., Bosco O., Patrucco E., Vivaldo M.C., Ricca M., Wymann M.P., Hirsch E., Montrucchio G., and Emanuelli G. Ablation of phosphoinositide 3-kinase-gamma reduces the severity of acute pancreatitis. Am J Pathol 165 (2004) 2003-2011
17. Bhatia M., Saluja A.K., Singh V.P., Frossard J.L., Lee H.S., Bhagat L., Gerard C., and Steer M.L. Complement factor C5a exerts an anti-inflammatory effect in acute pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol 280 (2001) G974-G978
18. Richardson J.D., Kilo S., and Hargreaves K.M. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75 (1998) 111-119
19. Liddle R.A., and Nathan J.D. Neurogenic inflammation and pancreatitis. Pancreatology 4 (2004) 551-559 discussion 559-560
20. Bhatia M., Wong F.L., Cao Y., Lau H.Y., Huang J., Puneet P., and Chevali L. Pathophysiology of acute pancreatitis. Pancreatology 5 (2005) 132-144
21. Matsuda K., Mikami Y., Takeda K., Fukuyama S., Egawa S., Sunamura M., Maruyama I., and Matsuno S. The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis. Tohoku J Exp Med 207 (2005) 99-107
22. Kunos G., and Pacher P. Cannabinoids cool the intestine. Nat Med 10 (2004) 678-679
23. Gebhart G.F.J.J. Bonica Lecture--2000: Physiology, pathophysiology, and pharmacology of visceral pain. Reg Anesth Pain Med 25 (2000) 632-638